Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-46 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
filingDate |
2001-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e34d558c0ab5fbe5e67a7fc83e4c00f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b5b5216e61116b0d686d3eedc14be12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab2ec6e60b3107e6e2eeb369dec1bd79 |
publicationDate |
2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002121118-A |
titleOfInvention |
Use of a Prostaglandin EP-3 Receptor Antagonist as a Cosmetic for Reducing, Reducing, or Stopping Head and Other Hair Loss |
abstract |
(57) Abstract: To provide cosmetics for reducing, reducing or stopping the loss of head hair and other body hair. The cosmetic composition comprises at least one prostaglandin EP- in a cosmetically acceptable medium. 3 antagonists. The agonist is contained in a ratio of 0.001% by mass to 10% by mass, preferably 0.01% by mass to 5% by mass based on the total mass of the cosmetic composition. The cosmetic composition is 0.001 based on its total mass. It may comprise from 10% to 10%, preferably from 0.1% to 5%, by weight of a prostaglandin EP-3 receptor antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015129149-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005529886-A |
priorityDate |
2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |